|
ZNF500 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.24380000000335E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.205800E-04 |
| Normal-vs-Stage2 |
1.751790E-02 |
| Normal-vs-Stage3 |
1.019120E-04 |
| Normal-vs-Stage4 |
7.640200E-04 |
| Stage1-vs-Stage2 |
7.172800E-01 |
| Stage1-vs-Stage3 |
3.244400E-01 |
| Stage1-vs-Stage4 |
5.313600E-01 |
| Stage2-vs-Stage3 |
3.348800E-01 |
| Stage2-vs-Stage4 |
4.409200E-01 |
| Stage3-vs-Stage4 |
9.029400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9550999999991E-05 |
| Normal-vs-AfricanAmerican |
1.643360E-01 |
| Normal-vs-Asian |
8.760500E-03 |
| Caucasian-vs-AfricanAmerican |
2.211200E-01 |
| Caucasian-vs-Asian |
5.852200E-01 |
| AfricanAmerican-vs-Asian |
4.489200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.679400E-03 |
| Normal-vs-Female |
1.83247999999692E-05 |
| Male-vs-Female |
3.106400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.631700E-04 |
| Normal-vs-Age(41-60Yrs) |
4.226100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.578500E-04 |
| Normal-vs-Age(81-100Yrs) |
5.586300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.658600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.199200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.303800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.059600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.967800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.569600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.877800E-03 |
| Classical-VS-Follicular |
6.559900E-02 |
| Classical-VS-Other |
4.071000E-01 |
| Classical-VS-Normal |
1.044510E-03 |
| Tall-VS-Follicular |
3.243200E-01 |
| Tall-VS-Other |
8.021400E-01 |
| Tall-VS-Normal |
1.54463999999521E-05 |
| Follicular-VS-Other |
9.173400E-01 |
| Follicular-VS-Normal |
2.637900E-04 |
| Other-VS-Normal |
7.366500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.824900E-04 |
| Normal-vs-N1 |
1.446290E-04 |
| N0-vs-N1 |
1.601030E-01 |
|
|
